NYSE - Nasdaq Real Time Price USD

Solventum Corporation (SOLV)

Compare
68.10 -1.12 (-1.62%)
At close: September 26 at 4:00 PM EDT
67.88 -0.22 (-0.32%)
After hours: September 26 at 7:54 PM EDT
Loading Chart for SOLV
DELL
  • Previous Close 69.22
  • Open 68.86
  • Bid 67.88 x 800
  • Ask 68.78 x 1100
  • Day's Range 67.89 - 69.05
  • 52 Week Range 47.16 - 73.40
  • Volume 1,951,673
  • Avg. Volume 1,407,101
  • Market Cap (intraday) 11.762B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 29.10
  • EPS (TTM) 2.34
  • Earnings Date Aug 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 63.25

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

www.solventum.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SOLV

View More

Performance Overview: SOLV

Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SOLV
1.52%
S&P 500
9.57%

1-Year Return

SOLV
1.52%
S&P 500
9.57%

3-Year Return

SOLV
1.52%
S&P 500
9.57%

5-Year Return

SOLV
1.52%
S&P 500
9.57%

Compare To: SOLV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SOLV

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    11.96B

  • Enterprise Value

    19.36B

  • Trailing P/E

    29.59

  • Forward P/E

    12.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.45

  • Price/Book (mrq)

    4.17

  • Enterprise Value/Revenue

    2.35

  • Enterprise Value/EBITDA

    10.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.89%

  • Return on Assets (ttm)

    6.78%

  • Return on Equity (ttm)

    14.50%

  • Revenue (ttm)

    8.21B

  • Net Income Avi to Common (ttm)

    1.06B

  • Diluted EPS (ttm)

    2.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    897M

  • Total Debt/Equity (mrq)

    289.71%

  • Levered Free Cash Flow (ttm)

    2.2B

Research Analysis: SOLV

View More

Company Insights: SOLV

Research Reports: SOLV

View More

People Also Watch